Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Apeiron Biologics.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Sumitomo Dainippon Pharma.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 1st Biotherapeutics, Altimmune, Arcus, Ascletis, Astrazeneca, Basilea, Daiichi Sankyo, Dyadic, Dynavax, Evqlv, Generex, Glenmark, Hikma, Hypera, Immunoprecise Antibodies, Innovation, Nektar, Novavax, Pfizer, Pvp Biologics, Redhill, Sonoma, Sumitomo Dainippon, Taiho, Takeda, Twoxar, Vir, Wuxi.

Quarterly snapshots from biopharma companies with marketed products, including: Amicus Therapeutics.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Biolexis, Outlook.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Access Vascular, Life Spine, Mauna Kea Technologies, Tivic Health, Xatek.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adapthealth, Ao Foundation, Bioventrix, Capella Imaging, Curium, Dmh Worldwide, Healthline Medical Equipment, Ekare, Icotec, Infantdx, International Business Machines, Nalu Medical, Natera, Nevro, Northstar Medical Technologies, Pillo Health, Synergy Laboratories, Zevacor Molecular.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Cernostics, Integrity Implants, Moleculight, Pixium Vision, Quanta, Sensus Healthcare, Treace Medical.

Med-tech firms raising money in public or private financings, including: Daxor.

New hires and promotions in the med-tech industry, including: Catasys, Cerus, Integer Holdings, Microbot Medical, Orchestra Biomed, Outset Medical, Venus Concept.